Related Experiment Video
Updated: Jul 27, 2026

07:45
A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
Published on: June 27, 2011
Serum protein binding of desmethyl-methsuximide
1Swiss Epilepsy Centre, Zurich, Switzerland.
Clinical Neuropharmacology
|August 12, 1999
Abstract:
Serum protein binding of desmethyl-methsuximide (DM-MSM) in serum from 23 patients on polytherapy were determined using ultrafiltration and high-performance liquid chromatography. Desmethyl-methsuximide, The active metabolite of methsuximide (MSM), was found to have a moderate protein binding ranging between 45% and 60%.

